Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 18

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 18
---
 such returns, reports and declarations. and (iii) has set aside on its books provision reasonably
adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.

If we are unable to continue to satisfy the app licable continued l isting requirements of Nasdaq, our Common Stock could be de listed, and we and our stockholders could face s ignificant mater ial adverse consequen ces.

In order to remain
listed on Nasdaq, we must satisfy minimum financial and other continued listing requirements
and standards, including those regarding director independence
and independent committee requirements, minimum
stockholders’ equity, minimum
share price, and certain corporate governance
requirements.

As of November 4, 2025, the
Company has regained compliance with
the Minimum Bid Price Requirement and the Annual Meeting Requirement. We
cannot assure you that we will be able to continue
to comply with the applicable listing standards.
If we are not able to comply with applicable
listing standards, our shares of Common Stock will be subject to delisting.

<div align='center'>S-10</div>

If Nasdaq
delists our Common Stock from trading on its exchange
for failure to meet comply with the Bid
Price Rule, or any other listing standards, we
and our stockholders could face significant material
adverse consequences including, but not limited
to:

| ● | a limited availability                                                                            
 of market quotations for our securities;                                                          |
| ● | a reduction in liquidity and market price                                                         
 of our Common Stock;                                                                              |
| ● | a reduction in the number of investors willing                                                    
 to hold or acquire our Common Stock, which could negatively                                       
 impact our ability to raise equity financing;                                                     |
| ● | a determination that our Common                                                                   
 Stock is a “penny stock,” which will                                                              
 require brokers trading in our Common Stock to adhere to more stringent rules, possibly resulting 
 in a reduced level of trading activity in the                                                     
 secondary trading market for our Common Stock;                                                    |
| ● | a limited amount of analyst coverage;                                                             
 and                                                                                               |
| ● | a decreased ability to issue additional                                                           
 securities or obtain additional financing in                                                      
 the future.                                                                                       |

We will have broad discret ion in the use of the net proceeds from this o ffering and may not use them e ffectivel y.

We
currently intend to use the net proceeds from the offering
of the Common Stock under this prospectus